NEOGENE THERAPEUTICS
Neogene Therapeutics provides cancer patients with T cell therapies targeting mutated proteins called neo-antigens. The company is developing novel technologies to enable the engineering of โdesigner T cellsโ with neo-antigen specificities that display an optimized ability to seek and destroy cancer cells. Neogene's platform allows for the isolation of neo-antigen specific TCR genes from tumor biopsies that are routinely obtained from cancer patients during treatment. The tumor-infiltrating... lymphocytes (TIL) obtained by these tumor biopsies frequently express TCRs specific for mutated proteins found in cancer cells (neo-antigens). The companyโs proprietary technology uses state-of-the-art DNA sequencing, DNA synthesis and genetic screening tools to identify such neo-antigen specific T cell receptor genes within tumor biopsies with high sensitivity, specificity and at scale.
NEOGENE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.neogene.com
Total Employee:
11+
Status:
Active
Total Funding:
125 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Sitelinks Search Box
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
Pontifax
Pontifax investment in Series A - Neogene Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series A - Neogene Therapeutics
Two River
Two River investment in Series A - Neogene Therapeutics
Jeito Capital
Jeito Capital investment in Series A - Neogene Therapeutics
Vida Ventures
Vida Ventures investment in Series A - Neogene Therapeutics
TPG
TPG investment in Series A - Neogene Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Neogene Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series A - Neogene Therapeutics
Key Employee Changes
Official Site Inspections
http://www.neogene.com Semrush global rank: 4.36 M Semrush visits lastest month: 2.6 K
- Host name: 13.137.62.50.host.secureserver.net
- IP address: 50.62.137.13
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260